Asset Allocation

As of February 28, 2026.
Type % Net
Cash 0.42%
Stock 20.50%
Bond 74.32%
Convertible 0.03%
Preferred 0.00%
Other 4.73%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 85.89%    % Emerging Markets: 2.45%    % Unidentified Markets: 11.66%

Americas 82.17%
79.59%
Canada 1.45%
United States 78.14%
2.58%
Brazil 0.72%
Chile 0.70%
Mexico 0.40%
As of February 28, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 3.95%
United Kingdom 1.38%
2.57%
France 0.80%
Germany 0.37%
Ireland 0.43%
Netherlands 0.34%
Sweden 0.14%
0.00%
0.00%
Greater Asia 2.21%
Japan 0.38%
0.64%
Australia 0.64%
0.87%
Taiwan 0.87%
0.32%
China 0.32%
Unidentified Region 11.66%

Bond Credit Quality Exposure

AAA 11.09%
AA 44.10%
A 14.45%
BBB 15.10%
BB 0.15%
B 0.00%
Below B 0.01%
    CCC 0.00%
    CC 0.01%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.26%
Not Available 14.83%
Short Term 0.00%
As of February 28, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
36.13%
Materials
5.53%
Consumer Discretionary
11.10%
Financials
16.24%
Real Estate
3.25%
Sensitive
48.05%
Communication Services
8.35%
Energy
0.00%
Industrials
10.67%
Information Technology
29.04%
Defensive
11.57%
Consumer Staples
0.00%
Health Care
10.43%
Utilities
1.14%
Not Classified
4.24%
Non Classified Equity
0.00%
Not Classified - Non Equity
4.24%
As of February 28, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of February 28, 2026
Type % Net
Government 38.41%
Corporate 24.71%
Securitized 34.31%
Municipal 2.34%
Other 0.23%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
2.80%
Less than 1 Year
2.80%
Intermediate
53.93%
1 to 3 Years
4.32%
3 to 5 Years
17.55%
5 to 10 Years
32.06%
Long Term
43.04%
10 to 20 Years
16.49%
20 to 30 Years
20.37%
Over 30 Years
6.19%
Other
0.23%
As of February 28, 2026
View Bond Maturity Exposure
Start Trial